Reference 2019-217

REF:         2019-217  

Subject:     Vyxeos to treat patients with Acute Myeloid Leukemia  

    

 

Request:

  1. Is Vyxeos an approved therapy on the trust formulary for patients with Acute Myeloid Leukemia (AML)?
  2. What e-prescribing system does the Trust use?
  3. Is Vyxeos now available to be prescribed through the Trust’s e-prescribing system?

 

 

Response:

Is Vyxeos an approved therapy on the trust formulary for patients with Acute Myeloid Leukemia (AML)? When a request is made to add to the formulary this will be considered by our Drugs and Therapeutics Committee (DTC)
What e-prescribing system does the Trust use? iQemo
Is Vyxeos now available to be prescribed through the Trust’s e-prescribing system? Will be made available once approved by our Drugs and Therapeutics Committee (DTC).